Alexander Moldavsky

Alexander Moldavsky demonstrates extensive experience in the pharmaceutical and chemical engineering sectors. In the current role as Head of Innovation and Product Development at Abbott since August 2020, Alexander Moldavsky leads product advancement initiatives. Prior to this, Alexander Moldavsky served as Chief Executive Officer at Globalchempharm from May 2019 to June 2020 and held the position of Director and Head of the Chemical-Pharmaceutical Division at BIOCAD from November 2014 to April 2019, overseeing the development and manufacturing of active pharmaceutical ingredients. At Teva Pharmaceuticals, Alexander Moldavsky advanced from Process Technology Manager in Global R&D to Project Manager for Technology R&D, managing teams and international projects. Academic qualifications include an MBA from Technion - Israel Institute of Technology, a PhD in Chemical Process Technology from Saint-Petersburg State Chemical Pharmaceutical University, and multiple degrees in Chemical Engineering from Technion.